Report Store Get Proposal

Home Blog Immunological and autoimmune disorders 5

Immunological and Autoimmune Disorders

stelara-biosimilar-wezlana

Articles

Could Amgen’s Biosimilar Wezlana Pose a Challenge to Johnson & Johnson’s Stelara

The FDA recently approved Amgen’s Wezlana (ustekinumab-auub) for various inflammatory conditions, marking the first biosimilar approval referencing the popular J&J drug Stelara (ustekinumab). Wezlana, mirroring its reference product, is approved for treating multiple inflammatory diseases in adults, including moderate to severe plaque psoriasis, active psoriatic arthritis, and moderately to severely active Crohn’s disease and ulcerative colitis. Additionally, this biosimilar is suitable for use in children aged six years and above with active psoriatic arthritis and moderate to severe plaque psoriasis. Amgen’s Wezlana joins the ranks of interchangeable biosimil...

Explore More...

Pharma News for Aktis, Alcon and Takeda

Aktis’s Novel Targeted Alpha Radiopharmaceuticals; Koye Partners with Sonde Health; Novartis to Spin Off Sandoz Business; Alcon to Buy Aerie Pharma; Fast Track Designation to Merck’s MK-2060; FDA Approves Ibrutinib for Chronic GvHD; French Authorities Clears BrainVectis’s Clinical Trial; Takeda’s Dengue Vaccine TAK-003 Gets Approval in Indonesia

Latest MedTech News for CereVasc and Nanopath

CereVasc’s eShunt System Study; FDA Approves NGS-Based CDx for Trastuzumab Deruxtecan; Nanopath Secures $10 Million Funding; BD, Accelerate Diagnostics Announce Collaboration; Avails Medical’s Clinical Trials for eQUANT; Movano Ring Exceeds Accuracy Targets for SpO2 & Heart Rate Monitoring

generalized-myasthenia-gravis-treatment-market

Can FcRn Antagonists Be The Game-Changer in the Generalized Myasthenia Gravis (gMG) Treatment Market?

Pharma News for Sanofi, Bayer, Spero

AstraZeneca’s Imfinzi Shows Positive Results; Novartis Announces Results of Tislelizumab; FDA Grants Orphan Drug Designation to Evorpacept; EU Approves Sanofi’s Xenpozyme; Bayer’s Kerendia Approves in China; FDA Breakthrough Therapy Designation to Talquetamab; FDA Puts Clinical Hold on Sanofi’s Tolebrutinib; FDA Rejects Spero’s Tebipenem

MedTech Updates for Ibex and Senseonics

CE Mark to Ibex’s Gastric Cancer Detection System; Senseonics’s Eversense E3 Continuous Glucose Monitoring System; NEUSPERA’s NUVELLA SYSTEM; Conformal Medical Initiates CONFORM Pivotal Trial; Meridian Launches New qPCR Master Mixes for Stool Samples; Sentinel Diagnostics Launches SENTiFIT 800

Pharma News and Updates for GSK, Roche, and Owkin

GSK’s RSV Vaccine Clears Phase III Test in Adults; Roche’s Tecentriq for Adjuvant NSCLC; Owkin Bags $ 180 million from BMS; EU Approves Roche’s Mosunetuzumab; Dostarlimab Elicits Clinical Complete Response in dMMR Rectal Cancer; FDA Backs Bluebird’s CALD Gene Therapy; Takeda’s Dengue Fever Vaccine TAK-003; FDA Approves Dupilumab

at-home medical equipment and devices

How At-Home Medical Equipment is Improving the Quality of Medical Care?

MedTech News and Updates for GenScript, Biomerics, MedAlliance, Filterlex

GenScript Enters Distribution Agreement with EUROIMMUN; Biomerics’s New Facility in Galway (Ireland); MedAlliance’s SELUTION SLR DEB; OmniGuide’s RevoLix HTL Hybrid Thulium Laser; Filterlex’s CAPTIS Full-Body Embolic Protection Device; Orthofix’s M6-C Artificial Cervical Disc

Pharma News and Updates for BMS, Mirati, Roche, Dermavant, Merck

Bristol-Myers Squibb’s Opdivo Approval; Mirati’s KRAS-inhibitor Adagrasib; J&J and Legend Biotech’s CAR-T Carvykti Approval; Roche’s Glofitamab; Arena Pharma’s Etrasimod Phase 3 Trials; FDA Approves Dermavant’s Vtama; FDA Approves Novartis’ Cell Therapy; NICE Approves Merck’s Keytruda

Pharma News For Sanofi, Bayer, Innoviva

PTC Therapeutics’ Gene Therapy Upstaza; Sanofi and Regeneron’s Dupixent; Bayer CAR-T Collaboration with Atara; FDA Accepts Biohaven’s Zavegepant; AbbVie Files FDA Approval for ABBV-951; Innoviva to Acquire Entasis; FDA Orphan Drug Designation to XMT-2056; FDA Approves Azacitidine for Juvenile Myelomonocytic Leukemia

Pharma News and Update for Incyte and Aptose

AstraZeneca’s Farxiga; Incyte’s Jakavi; FDA Fast Track Status to HM43239 for R/R AML; Idorsia’s Insomnia Drug Quviviq; EU Approves Kymirah For Follicular Lymphoma; Perrigo Acquires HRA Pharma; Janssen Submits Marketing Authorisation Application to EMA

food-allergy-treatment-landscape

Most Promising Therapies in the Food Allergy Treatment Market

MedTech News and Updates for GE, Vivalink, and Vektor

GE and Medtronic’s Collaboration; Vivalink’s Multi-Vital Blood Pressure Patch; Foldax’s TRIA Biopolymer Surgical Aortic Heart Valve; Vektor Medical’s vMap Clinical Validation Study; iSono’s ATUS System; Mirvie’s Test to Identify Risk of Preeclampsia

Pharma News and Updates for AstraZeneca, Supernus, and BMS

VBL Therapeutics’ VB-111 (ofranergene obadenovec); BMS’s mavacamten (Camzyos); Merck’s KEYTRUDA; AstraZeneca and Daiichi’s Enhertu; Pfizer/Biohaven’s VYDURA (rimegepant); AstraZeneca’s Ultomiris; Supernus’s Viloxazine (Qlebree); AbbVie’s Rinvoq

Ankylosing Spondylitis Treatment Market Analysis

Investigating the Pipeline for Ankylosing Spondylitis Treatment Landscape

Pharma News and Updates for Sanofi ViiV Argenx Novartis UCB Kyowa

Sanofi’s Rare Disease Drug Xenpozyme’ Approval; FDA Approves Novartis’ Pluvicto; AstraZeneca’s Imfinzi Trial Result; FDA’s Green Signal to Argenx’ Vyvgart; ViiV Healthcare and J&J’s HIV Treatment Cabenuva; UCB’s FINTEPLA Approval; Cullinan’s Update for CLN-081; MEI Pharma & Kyowa’s Zandelisib Approval

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly